AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The …
List of 22 Tardive Dyskinesia Medications Compared - Drugs.com
Mar 5, 2024 · Treatments for tardive dyskinesia include deutetrabenazine (Austedo, Austedo XR), valbenzaine (Ingrezza), tetrabenazine (Xenazine), amantadine, vitamin B6 (pyridoxine) and …
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …
AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …
Austedo Dosage: Forms, Strengths, How to Take, and More
Oct 10, 2025 · Austedo is used to treat tardive dyskinesia and chorea associated with Huntington’s disease. Learn what the recommended dosages are, how to take the drug, and …
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia …
May 30, 2024 · The FDA has approved Austedo XR as a once-daily pill treatment option for tardive dyskinesia and Huntington disease chorea control.
Patients Taking AUSTEDO XR® (deutetrabenazine) extended …
Sep 20, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis …
Austedo dosage: Form, strengths, how to take, and more
Sep 25, 2025 · Austedo and Austedo XR treat tardive dyskinesia and chorea related to Huntington’s disease in adults. The dosage varies depending on the condition. Austedo …
Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). …
FDA Approves One Pill, Once-Daily Tablets of Deutetrabenazine …
May 30, 2024 · The newly added tablet strengths allow for greater flexibility when selecting or adjusting dosing for deutetrabenazine. The FDA has approved a new one-pill, once-daily tablet …
Treatments – National Organization for Tardive Dyskinesia
VMAT2 inhibitors: There are two FDA-approved drugs to treat tardive dyskinesia, Ingrezza (valbenazine) and Austedo (deutetrabenazine). These medications were approved in 2017 …